Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001033486 | SCV001196793 | pathogenic | Hermansky-Pudlak syndrome 2 | 2022-03-19 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 15-22 of the AP3B1 gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with AP3B1-related conditions. This variant disrupts a region of the AP3B1 protein in which other variant(s) (Deletion (Exon 15)) have been determined to be pathogenic (PMID: 16537806). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |